Tyson Foods shares declined following its third-quarter earnings report, which likely missed market expectations. Conversely, Bristol-Myers Squibb stock surged amid speculation of a potential acquisition by AstraZeneca.
Tyson Foods Falls on Q3 Results; Bristol-Myers Squibb Surges on Acquisition Talk
earnings-reportM&A-speculationpharmaceuticalsconsumer-staples



